| Document |
Document Title |
|
WO/2020/218003A1 |
Provided are: an N,N'-diarylurea derivative represented by general formula (1) (in formula (1), Z is a divalent organic group; R is an alkyl group, an alkenyl group, an alkyloxyalkyl group, an aralkyl group, an aryl group, an alkylsulfan...
|
|
WO/2020/212298A1 |
The present application refers to a process for providing anhydrous alkane sulfonic acid in purified form.
|
|
WO/2020/212543A1 |
The present invention relates to novel ophthalmic devices comprising polymerized compounds comprising a photoactive unit, said polymerized compounds, and special monomer compounds being particularly suitable for compositions and ophthalm...
|
|
WO/2020/212299A1 |
The present invention relates to a process for manufacturing of anhydrous methanesulfonic acid (MSA) and to methanesulfonic acid manufactured by said process and its uses.
|
|
WO/2020/187893A1 |
The present invention refers to a method for the production of alkane sulfonic acid, in which SO3 and an alkane are contacted with each other in the presence of a solvent, said solvent does constitute a superacid and the combination of s...
|
|
WO/2020/187155A1 |
Use of an apocynin dimer analogue derivative in preparing a medicament or a health care product for preventing and treating Parkinson's disease. The structure of the apocynin dimer analogue derivative is as shown in formula I. The apocyn...
|
|
WO/2020/187902A1 |
The present invention refers to a method for the production of haloalkane sulfonic acid, in which SO3 and an haloalkane are contacted with each other in the presence of a solvent, said solvent does not constitute a superacid and the comb...
|
|
WO/2020/187901A1 |
The present invention refers to a method for the production of haloalkanesulfonic acid, in which SO3 and an haloalkaneare contacted with each other in the presence of a solvent, said solvent does constitute a superacid and the combinatio...
|
|
WO/2020/187897A1 |
The present invention refers to a method for the production of alkane sulfonic acid, in which SO and an alkane are contacted with each other in the presence of a solvent, said solvent does not constitute a superacid and the combination o...
|
|
WO/2020/185640A1 |
A method of treating a female patient suffering from non-small cell lung cancer includes the step of administering to the patient in need thereof a composition of 2,2'-dithio-bis-ethane sulfonate, or a pharmaceutically-acceptable salt th...
|
|
WO/2020/175495A1 |
Provided is a method for producing a salt by reacting M+X- with YH so as to generate XH and M+Y-, and then removing the generated XH so as to obtain M+Y-. M+X- is a salt of a cation represented by M+ and an anion represented by X-. M+Y- ...
|
|
WO/2020/172075A1 |
Disclosed herein are novel solid forms of FXR agonist of Formula (I). The disclosure also relates to pharmaceutical compositions containing one or more of the solid forms disclosed herein, as well as methods of using the solid forms in t...
|
|
WO/2020/165062A1 |
Compounds of the formula (I) in which R1, R2, X, Y and Z have the meanings indicated in Claim 1, are inhibitors of c-Kit kinase, and can be employed for the treatment of cancer.
|
|
WO/2020/159007A1 |
The present invention relates to a method for synthesizing acyloxybenzenesulfonate, which is a bleaching activator, from an aqueous solution at a low temperature. The production unit cost can be reduced due to the production being from a...
|
|
WO/2020/158537A1 |
The main purpose of the present invention is to provide a compound with excellent balance between acid generation sensitivity and the effect of enabling achieving a composition with little color change. This purpose is met by providing...
|
|
WO/2020/148383A1 |
The present invention relates to novel bisazo compounds of formula (I) a process for preparing said compounds, the use of said compounds in a dyeing or printing process, a process for dyeing or printing a substrate in a trichromatic dyei...
|
|
WO/2020/144098A1 |
The invention relates to surfactants of the general formula (I), wherein R is hydrogen or a linear or branched alkyl-, alkenyl-, alkylaryl- or alkenylaryl group with 5 to 25 C atoms, n is a number from 1 to 21 and m is a number from 0 to...
|
|
WO/2020/145043A1 |
Provided are: a novel sulfonium salt which exhibits high photosensitivity to g rays or h rays; and a novel photoacid generator containing a sulfonium salt which exhibits high photosensitivity to g rays or h rays, high solubility in a sol...
|
|
WO/2020/138389A1 |
Provided are: a novel nanoparticle; a contrast agent for magnetic resonance imaging comprising the same; and a zwitterionic ligand compound to be used in the production of the nanoparticle. The contrast agent for MRI according to the pre...
|
|
WO/2020/138377A1 |
The purpose of the present invention is to provide a highly practical electrolyte solution which has high oxidation resistance and which enables the repeated dissolution/precipitation of magnesium to proceed stably. The present inventi...
|
|
WO/2020/131895A1 |
The present invention provides improved methods for the preparation of substituted heterocycle fused gamma-carbolines, intermediates useful in producing them and methods for producing such intermediates and such heterocycle fused gamma-c...
|
|
WO/2020/131911A1 |
The present invention provides improved methods for the preparation of substituted heterocycle fused gamma-carbolines, intermediates useful in producing them and methods for producing such intermediates and such heterocycle fused gamma-c...
|
|
WO/2020/126855A1 |
The present invention relates to the use of a mixture of methanesulfonic acid and sulfuric acid as an acid and a substitute for methanesulfonic acid and/or mineral acids, especially hydrochloric acid, nitric acid, sulfuric acid and/or ph...
|
|
WO/2020/123792A1 |
The present disclosure includes compositions and methods for improved DNA amplification reactions. In particular, the present disclosure provides compositions and methods for hot-start PCR applications using DNA polymerase inhibitors tha...
|
|
WO/2020/122113A1 |
A charge transporting varnish, which comprises a charge-transporting material, a high-molecular compound represented by formula (I) and an organic solvent, can provide a highly solvent-resistant thin film. By applying this thin film to a...
|
|
WO/2020/117654A1 |
The invention is directed at esylate and salicylate salts of cis-N-cyclohexyl-N-ethyl-3-(3-chloro-4-cyclohexylphenyl)prop
-2-enylamine and their pharmaceutical composition. The invention is also directed at the use esylate and salicylate...
|
|
WO/2020/112941A2 |
The present disclosure relates to solid state forms of Lumateperone besylate, processes for preparation thereof and pharmaceutical compositions thereof.
|
|
WO/2020/104634A1 |
This invention relates to compounds of general formula: wherein R0A and R0B are independently selected from hydrogen and pharmaceutically acceptable cations; and RA and RB are identical and selected from amide, carbamate, sulphonamide, a...
|
|
WO/2020/102672A1 |
The instant disclosure relates to hydrocarbyl- (e.g., alkyl-) benzene sulfonate detergents and their salts, where the hydrocarbyl group includes moieties equivalent to 5 to 10 carbon branched polyene compounds. Such compounds and their s...
|
|
WO/2020/098492A1 |
The present invention relates to a crystalline form of compound 3- ( (L-valyl) amino) -l-propanesulfonic acid, preparation method and uses thereof.
|
|
WO/2020/096019A1 |
The present invention provides a polyisocyanate composition and the like, which contains tertiary ammonium cations of an amine compound and a polyisocyanate that contains a sulfonate anion group in each molecule, and which is configured ...
|
|
WO/2020/095322A1 |
Disclosed herein is an efficacious process for preparation of highly purified Glycopyrrolate tosylate in high yield. The process is being cost effective, environment friendly and easily scalable to high volume industrial production.
|
|
WO/2020/076122A1 |
The present specification provides a compound, a photoresist composition comprising same, a photoresist pattern comprising same, and a method for manufacturing a photoresist pattern.
|
|
WO/2020/064466A1 |
The present invention relates to novel uses of organic peroxoacids comprising functional groups as catalysts in the preparation of alkane sulfonic acids from alkanes and sulfur trioxide, methods for the production of alkane sulfonic acid...
|
|
WO/2020/064515A1 |
The present invention relates to the use of cations or compounds forming stable cations in the production of alkane sulfonic acids as well as methods to produce methane sulfonic acids employing the ations as catalyst.
|
|
WO/2020/065668A1 |
The present invention relates to a crystalline form of 1-cyclopropyl-8-methyl-7- (5-methyl-6-(methylamino)pyridin-3-yl)-4-oxo-1,4-dihydroquin
oline-3-carboxylic acid the compound of formula-1, which is represented by the following struct...
|
|
WO/2020/064815A1 |
A crystalline form of treosulfan and methods to prepare it are described. This crystalline form of treosulfan is useful in pharmaceutical compositions for the treatment of cancer and for conditioning therapy before transplantation of bon...
|
|
WO/2020/064753A1 |
The invention discloses a method for the preparation of potassium 5-iodo-2-carboxybenzene sulfonate by diazotization of 5-amino-2-carboxybenzene sulfonate and subsequent reaction with KI.
|
|
WO/2020/061885A1 |
Disclosed in the present utility model is a production system for naphthalenesulfonic acid, comprising a reaction kettle, a devolatilization device, a collection device, a separating device, which are connected in sequence, and also a pr...
|
|
WO/2020/064573A1 |
The present invention relates to novel uses of compounds comprising heterolytically cleavable bonds as catalysts in the preparation of alkanesulfonic acids from alkanes and sulfur trioxide, methods for the production of alkanesulfonic ac...
|
|
WO/2020/060153A1 |
The present invention provides a compound exhibiting excellent heat resistance, and a colored resin composition, a color filter and a display device comprising same.
|
|
WO/2020/052577A1 |
A process for producing H acid by recycling an alkali fusion mother liquor. The alkali fusion mother liquor is used as a neutralization liquor for a denitration reaction liquor, or a neutralization liquor for a denitration liquor after c...
|
|
WO/2020/053803A1 |
The present disclosure relates to spun ABPBI fibers and a process for the preparing spun ABPBI fibers using high molecular weight ABPBI dope solution suitable for spinning. The present disclosure further relates to the process for prepar...
|
|
WO/2020/054287A1 |
The present invention provides a method for purifying a target peptide, the method including a step for mixing, in the presence of a sulfonate compound, a solvent with a peptide obtained through peptide synthesis to obtain a solid, and c...
|
|
WO/2020/050339A1 |
Provided is an industrially useful method for manufacturing (1R,2S)-2-{[((2,4-dimethylpyrimidine-5-yl)oxy}methyl]-2-(3-f
luorophenyl)-N-(5-fluoropyridine-2-yl)cyclopropane-1-carboxa
mide. In the present invention, (1R,2S)-2-{[((2,4-dimet...
|
|
WO/2020/048965A1 |
The present application refers to a method to produce alkane sulfonic acids as well as a device for carrying out said method.
|
|
WO/2020/044771A1 |
Provided is an actinic-ray-sensitive or radiation-sensitive resin composition from which a pattern having excellent LWR performance can be produced. Also provided are a resist film, a pattern formation method and an electronic device man...
|
|
WO/2020/045534A1 |
The present invention provides: an active-light-sensitive or radiation-sensitive resin composition containing (A) a resin that decomposes due to the action of an acid, the degree of solubility increasing in an alkaline developing solutio...
|
|
WO/2020/045535A1 |
The present invention provides: an active light sensitive or radiation sensitive resin composition that contains (A) a compound which generates an acid when irradiated with active light or radiation, and which has a specific structure; a...
|
|
WO/2020/037164A1 |
Provided herein are free base crystalline forms, crystalline salts, and an amorphous salts of omecamtiv mecarbil.
|
